Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
chloroquine/horúčka
Odkaz sa uloží do schránky
Strana 1 od 59 výsledky
Northeast COVID-19 and Pregnancy Study Group
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
General Objective: To determine the frequency of COVID-19 in pregnant and postpartum women admitted with flu syndrome, to evaluate the clinical and laboratory predictors of COVID-19 progression and to identify the factors associated with adverse maternal and perinatal / neonatal outcomes in six
Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
In December, 2019, an outbreak of pneumonia with unknown cause occurred in Wuhan city, the capital of Hubei province in China. On January 7th, the scientists succeeded to isolate a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). WHO nominated it as coronavirus
Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
More cases of COVID-19 pandemic are being reported daily around the world. It is highly infectious and, over 7 million people have been infected and more than 400,000 people have died globally till this date. Countries around the world are struggling to avoid the spread of this pandemic. The most
A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
This study was done from May 2nd to June 5th, 2020. The investigators included 181 patients who were tested positive for SARS-CoV-2 infection by RT PCR presented and the sample collected at Chokoria Upazila Health Complex, Cox's Bazar; Bangladesh. The PCR analysis of the collected sample was done at
Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Background
On February 21th 2020, SARS-CoV-2 outbreak erupted in Italy and, in the immediately subsequent period, all the Italian regional Health Systems had to face with an overwhelming increase of COVID-19 admissions requiring isolation, oxygen, ventilation and ICU beds.
The COVID-19 related
Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Background and rational of the study:
Novel corona virus (SARS-CoV-2) epidemic which stared from Wuhan in China is now a well established pandemic worldwide affecting more than 3 lakh people with more than 15000 mortality. As Italy, Spain, Germany, United Kingdom and USA have taken over from China
Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Recruitment Details.
The investigator enrolled, in the study, subjects with COVID-19 modest to moderate respiratory insufficiency (SIMEU clinical phenotypes 2-4) thus cared in an infectious disease ward.
To note that The Italian Society of Emergency and Urgency Medicine (SIMEU - Società Italiana di
Favipiravir vs Hydroxychloroquine in COVID -19
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV) and has developed into a pandemic with serious global public health and economic sequelae As of April 27, 2020 over 2,973,000 cases have been confirmed worldwide leading to
COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19)
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND
Since the first case of Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV-2) infection and its subsequent clinical manifestation (COronaVIrus Disease 19, COVID-19) in the city of Wuhan (Hubei, China) in December 2019, contagion abruptly spread to different regions of China
Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Dialyzable Leukocyte Extract (DLE) (Transferon oral®) is a dialyzed extract obtained from human leukocytes. Its active ingredient is a complex mixture of low molecular weight peptides obtained from dialysis (12 kDa), and subsequent ultrafiltration (10 kDa) of lysed leukocyte and platelet
Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients (SnPPIX)
Official Title: Efficacy of Based MRI Contrast Media Against Covid-19
_____________________________________________________________________________________________
VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
SARS-CoV-2 is a novel coronavirus disease (COVID-19) that presents with fever, cough, and shortness of breath, and has a mortality rate of 2-4%. Outcomes are worse among the elderly and those with cardiovascular, respiratory, cancer and other co-morbidities. Several treatments are also emerging as
COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Design: Retrospective cohort study that will review the data of patients seen in participating centers with a confirmed or probable diagnosis of COVID-19 between March and April 2020. Those patients who test positive for nasopharyngeal exudate for SARS-CoV-2 will be considered a confirmed case using
Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
STUDY OBJECTIVE The objective of the study is to estimate the frequency of cardiac arrhythmias and characterize the mode of death in patients with the novel coronavirus disease (SARS-CoV-2; COVID-19).
INTRODUCTION, RATIONALE The novel coronavirus (SARS-CoV-2) emerged in Wuhan, China, in late 2019
Najkompletnejšia databáza liečivých bylín podporovaná vedou
- Pracuje v 55 jazykoch
- Bylinné lieky podporené vedou
- Rozpoznávanie bylín podľa obrázka
- Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
- Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
- Vyhľadajte liečivé byliny podľa ich účinkov
- Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi
Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume
